David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Characterization and Importance of Air Leak After Lobectomy

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status.

Should lung transplantation be performed for patients on mechanical respiratory support? The US experience David P. Mason, MD, Lucy Thuita, MS, Edward.

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

Trevor Williams, MD, MPH, Brian C

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Effect of changes in postoperative spirometry on survival after lung transplantation David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,

Beyond the Aortic Root: Staged Open and Endovascular Repair of Arch and Descending Aorta in Patients With Connective Tissue Disorders Eric E. Roselli,

Robert J. Steffen, MD, Eugene H. Blackstone, MD, Nicholas G

Mitral Valve Surgery in the Adult Marfan Syndrome Patient

Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life Janne J. Jokinen, MD, Anu K. Turpeinen,

David P. Mason, MD, Jeevanantham Rajeswaran, MS, Sudish C

Surgical treatment of pseudoaneurysm of the thoracic aorta

Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm

Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery: Development of a Predictive Risk Algorithm Mitchell J. Magee, MD, Morley A. Herbert,

The Optimal Timing of Stage-2-Palliation After the Norwood Operation

Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome Soren Schenk, MD, Patrick M. McCarthy,

Reoperation After Mitral Valve Repair for Degenerative Disease

Bruce W. Lytle, MD, Eugene H. Blackstone, MD, Joseph F

Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Cardiac Surgery Colleen Gorman Koch, MD, MS, Farah Khandwala, MS, Liang.

Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair Douglas R. Johnston, MD, A. Marc Gillinov, MD,

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Bahaaldin Alsoufi, MD, Sally Cai, PhD, Glen S

A. Marc Gillinov, MD, Sekar Bhavani, MD, Eugene H

Too High for Transplantation

Amedeo Anselmi, MD, Gianfederico Possati, MD, Mario Gaudino, MD

Trevor Williams, MD, MPH, Brian C

Should lung transplantation be performed using donation after cardiac death? The United States experience David P. Mason, MD, Lucy Thuita, MS, Joan M.

Charles M. Wojnarski, MD, Lars G. Svensson, MD, PhD, Eric E

Observational Study on the Beneficial Effect of Preoperative Statins in Reducing Atrial Fibrillation After Coronary Surgery Giovanni Mariscalco, MD,

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Atrial fibrillation complicating lung cancer resection

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Use of Amiodarone After Major Lung Resection

Long-Term Durability of Bicuspid Aortic Valve Repair

Reduced survival in women after valve surgery for aortic regurgitationEffect of aortic enlargement and late aortic rupture Monica L. McDonald, MDa, Nicholas.

Farhang Yazdchi, MD, MS, Colleen G

Nicholas G. Smedira, MD, Katherine J. Hoercher, RN, Dustin Y

David P. Mason, MD, Lillian H. Batizy, MS, Jeffrey Wu, MD, Edward R

Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?

Distal aortic interventions after repair of ascending dissection: The argument for a more aggressive approach Eric E. Roselli, MD, Gabriel Loor, MD,

Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer Malcolm M DeCamp, MD, Thomas W Rice, MD, David J Adelstein,

Edward R. Nowicki, MD, MS, Gösta B. Pettersson, MD, PhD, Nicholas G

Comparative study of bronchial artery revascularization in lung transplantation Gösta B. Pettersson, MD, PhD, Karam Karam, MD, Lucy Thuita, MS, Douglas.

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Sudish C. Murthy, MD, PhD, Edward R. Nowicki, MD, MS, David P

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Third-time lung transplantation in a patient with cystic fibrosis

Impact of Anastomotic Airway Complications After Lung Transplantation

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Ryan K. Kaple, BS, Ross T. Murphy, MD, Linda.

Truncus Arteriosus Associated with Interrupted Aortic Arch in 50 Neonates: A Congenital Heart Surgeons Society Study Igor E. Konstantinov, MD, PhD, Tara.

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Patient and Surgical Factors Influencing Air Leak After Lung Volume Reduction Surgery: Lessons Learned From the National Emphysema Treatment Trial Malcolm.

Mohammed A Quader, MD, Patrick M McCarthy, MD, A

Aaron J. Lindsay, MD, Meng Xu, MS, Daniel I. Sessler, MD, Eugene H

Douglas R. Johnston, MD, Edward G

Endocarditis after mitral valve repair

David P. Mason, MD, Chase R. Brown, BS, Sudish C

Siva Raja, MD, PhD, Jay J. Idrees, MD, Eugene H

Pulmonary transplantation in Mounier-Kuhn syndrome: A case report

Lung Transplantation for Idiopathic Pulmonary Fibrosis

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,

Presentation transcript:

Atrial Fibrillation After Lung Transplantation: Timing, Risk Factors, and Treatment David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C. Murthy, MD, PhD, Ann M. McNeill, RN, Marie M. Budev, DO, Atul C. Mehta, MD, Gösta B. Pettersson, MD, PhD, Eugene H. Blackstone, MD The Annals of Thoracic Surgery Volume 84, Issue 6, Pages 1878-1884 (December 2007) DOI: 10.1016/j.athoracsur.2007.07.014 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig. 1 Incidence of atrial fibrillation or flutter (AF) after lung transplantation (hazard function). Solid line is the parametric estimate, and dashed lines are 68% confidence limits, equivalent to ±1 standard error. The Annals of Thoracic Surgery 2007 84, 1878-1884DOI: (10.1016/j.athoracsur.2007.07.014) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig. 2 Occurrence of atrial fibrillation or flutter (AF) within 10 days of lung transplantation. Nomogram from multivariable analysis with indication for transplant other than primary pulmonary hypertension. (A) Occurrence according to age at transplantation for a patient weighing 68 kg. (B) Occurrence according to weight at transplantation of a patient age 48 years. The solid line in each figure is the parametric estimate, and the dashed lines are 68% confidence limits, equivalent to ±1 standard error. The Annals of Thoracic Surgery 2007 84, 1878-1884DOI: (10.1016/j.athoracsur.2007.07.014) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig. 3 The percentage of patients who underwent respective treatments of postoperative atrial fibrillation or flutter after lung transplantation is indicated by black bars. The Annals of Thoracic Surgery 2007 84, 1878-1884DOI: (10.1016/j.athoracsur.2007.07.014) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig. 4 Survival after transplantation according to whether (filled circles, dashed line) or not (open circles, solid line) postoperative atrial fibrillation or flutter (AF) occurred. Starting point is 15 days posttransplantation (see Methods). Each symbol represents a death, vertical bars are 68% confidence limits equivalent to ±1 standard error, and numbers in parentheses are patients remaining at risk. The Annals of Thoracic Surgery 2007 84, 1878-1884DOI: (10.1016/j.athoracsur.2007.07.014) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions